Gilead Sciences (GILD) Leases (2010 - 2025)

Gilead Sciences (GILD) has 10 years of Leases data on file, last reported at $532.0 million in Q4 2025.

• For the quarter ending Q4 2025, Leases rose 3.3% year-over-year to $532.0 million; the trailing twelve-month figure through Dec 2025 stood at $532.0 million (up 3.3% YoY), and the FY2025 full-year result was $532.0 million, up 3.3% from the prior year.
• Leases for Q4 2025 stood at $532.0 million, up from $515.0 million in the prior quarter.
• Across five years, Leases topped out at $581.0 million in Q4 2023 and bottomed at $505.0 million in Q4 2022.
• The 5-year median for Leases is $532.0 million (2025), against an average of $535.0 million.
• The widest annual swing landed in 2021, when Leases dropped 16.1%; it then advanced 15.05% in 2023.
• A 5-year view of Leases shows it stood at $542.0 million in 2021, then declined by 6.83% to $505.0 million in 2022, then gained by 15.05% to $581.0 million in 2023, then slipped by 11.36% to $515.0 million in 2024, then increased by 3.3% to $532.0 million in 2025.
• The last three Leases figures came in at $532.0 million (Q4 2025), $515.0 million (Q4 2024), and $581.0 million (Q4 2023), per Business Quant data.

Peer Comparison